123 related articles for article (PubMed ID: 2318694)
1. Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study.
Marcial-Vega VA; Order SE; Lastner G; Cole PD; LaFrance N; O'Neill M
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):613-8. PubMed ID: 2318694
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy of Hodgkin's disease in early pregnancy: embryo dose measurements.
Mazonakis M; Varveris H; Fasoulaki M; Damilakis J
Radiother Oncol; 2003 Mar; 66(3):333-9. PubMed ID: 12742274
[TBL] [Abstract][Full Text] [Related]
3. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
[TBL] [Abstract][Full Text] [Related]
4. Thyroid dysfunction following mantle radiotherapy for Hodgkin's disease.
Nair N; Advani SH; Dinshaw KA
Int J Nucl Med Biol; 1984; 11(2):175-8. PubMed ID: 6480261
[No Abstract] [Full Text] [Related]
5. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin's disease.
Cygler J; Ding GX; Kendal W; Cross P
Med Dosim; 1997; 22(2):135-7. PubMed ID: 9243468
[TBL] [Abstract][Full Text] [Related]
6. Doses to radiation sensitive organs and structures located outside the radiotherapeutic target volume for four treatment situations.
Foo ML; McCullough EC; Foote RL; Pisansky TM; Shaw EG
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):403-17. PubMed ID: 8407417
[TBL] [Abstract][Full Text] [Related]
7. Thyroid dysfunction in children receiving neck irradiation for Hodgkin's disease.
Atahan IL; Yildiz F; Ozyar E; Uzal D
Radiat Med; 1998; 16(5):359-61. PubMed ID: 9862158
[TBL] [Abstract][Full Text] [Related]
8. Thyroid function after mantle irradiation in Hodgkin's disease.
Smith RE; Adler RA; Clark P; Brinck-Johnsen T; Tulloh ME; Colton T
JAMA; 1981 Jan; 245(1):46-9. PubMed ID: 6253696
[TBL] [Abstract][Full Text] [Related]
9. Measurement of radiation dose delivered to breast tissue during mantle field irradiation for Hodgkin's disease.
Kowalski A; Smith S
Med Dosim; 1998; 23(1):31-6. PubMed ID: 9586717
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease.
Peerboom PF; Hassink EA; Melkert R; DeWit L; Nooijen WJ; Bruning PF
Eur J Cancer; 1992; 28A(10):1716-8. PubMed ID: 1389492
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism and thyroiditis after therapy for Hodgkin's disease.
Illés A; Bíró E; Miltényi Z; Keresztes K; Váróczy L; András C; Sipka S; Bakó G
Acta Haematol; 2003; 109(1):11-7. PubMed ID: 12486317
[TBL] [Abstract][Full Text] [Related]
12. Thyroid volume is progressively reduced as a sequela of neck irradiation for childhood Hodgkin's disease.
Bossi G; Larizza D; Sommaruga G; Corbella F; Klersy C; Aricò M
Haematologica; 1998 Aug; 83(8):754-6. PubMed ID: 9793265
[TBL] [Abstract][Full Text] [Related]
13. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
14. Fluctuating thyroid dysfunction following irradiation of the neck for the treatment of Hodgkin's disease.
Porter AT; Ostrowski MJ
J R Soc Med; 1988 Jan; 81(1):45-6. PubMed ID: 3343672
[No Abstract] [Full Text] [Related]
15. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients.
Khoo VS; Liew KH; Crennan EC; D'Costa IM; Quong G
Australas Radiol; 1998 Feb; 42(1):52-7. PubMed ID: 9509606
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.
Woo SY; Fuller LM; Cundiff JH; Bondy ML; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F; Rodriguez MA; Cabanillas F
Int J Radiat Oncol Biol Phys; 1992; 23(2):407-12. PubMed ID: 1587764
[TBL] [Abstract][Full Text] [Related]
17. [Hypothyroid hypertrophic myopathy following mantle irradiation for Hodgkin's disease. A case].
Weber JC; Dufour P; Maloisel F; Tranchant C; Jung G; Damonte JC; Giron C; Oberling F
Rev Med Interne; 1991; 12(3):205-8. PubMed ID: 1896713
[TBL] [Abstract][Full Text] [Related]
18. Estimation of absorbed dose to thyroid in patients treated with radiotherapy for various cancers.
Gul A; Faaruq S; Abbasi NZ; Siddique T; Ali A; Shehzadi NN; Rahman MU; Khan AA; Rizvi QA; Ahmad F
Radiat Prot Dosimetry; 2013; 156(1):37-41. PubMed ID: 23520201
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
[TBL] [Abstract][Full Text] [Related]
20. Conceptus dose from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with MLCs.
Mazonakis M; Lyraraki E; Varveris C; Samara E; Zourari K; Damilakis J
Strahlenther Onkol; 2009 Jun; 185(6):355-63. PubMed ID: 19506818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
